BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35829797)

  • 1. ASO Author Reflections: Identifying and Understanding Disparities in Access to Surgery: Operable Lung Cancer in North Carolina.
    Burch AE; Wong JH; Irish WD
    Ann Surg Oncol; 2022 Nov; 29(12):7494-7495. PubMed ID: 35829797
    [No Abstract]   [Full Text] [Related]  

  • 2. Disparate Access to Surgery for Operable Carcinoma of the Lung in North Carolina.
    Oliver AL; Takahashi-Pipkin C; Wong JH; Burch AE; Irish WD
    Ann Surg Oncol; 2022 Nov; 29(12):7485-7493. PubMed ID: 35810228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ASO Author Reflections: Individualized Management of Lung Cancer Patients with a History of Cancer: Surgery or Not Requires Comprehensive Judgment.
    Li D; Deng C; Zhang Y; Chen H
    Ann Surg Oncol; 2023 Mar; 30(3):1541-1542. PubMed ID: 36617618
    [No Abstract]   [Full Text] [Related]  

  • 4. ASO Author Reflections: The Dissection of Station 4L Lymph Node for Left-Sided Non-Small Cell Lung Cancer Should Receive More Attention.
    Liu L; Zhang Z
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):705-706. PubMed ID: 31463697
    [No Abstract]   [Full Text] [Related]  

  • 5. ASO Author Reflections: Management to Prevent Postoperative Sarcopenia in Patients with Lung Cancer.
    Ushitani Y; Shimada Y
    Ann Surg Oncol; 2022 Oct; 29(11):6932-6933. PubMed ID: 35699816
    [No Abstract]   [Full Text] [Related]  

  • 6. ASO Author Reflections: Using Patient-Reported Outcomes to Evaluate Surgical Approaches for Locally Advanced Lung Cancer.
    Wei X; Yu H; Shi Q
    Ann Surg Oncol; 2021 Dec; 28(13):8372-8373. PubMed ID: 33993376
    [No Abstract]   [Full Text] [Related]  

  • 7. ASO Author Reflections: A Novel Concept to Decreasing the Technical Difficulty of Complex Pulmonary Segmentectomy.
    Zhu Y; Liu L
    Ann Surg Oncol; 2020 Aug; 27(8):3094-3095. PubMed ID: 32285280
    [No Abstract]   [Full Text] [Related]  

  • 8. ASO Author Reflections: Lobe-Specific Lymph Node Dissection for Early-Stage Non-small Cell Lung Cancer: A Long Way to Go in the Era of Minimally Invasive Thoracic Surgery.
    Deng HY; Zhou Q
    Ann Surg Oncol; 2020 Feb; 27(2):470-471. PubMed ID: 31620942
    [No Abstract]   [Full Text] [Related]  

  • 9. ASO Author Reflections: Which of Smoking Duration or Smoking Intensity Contributes to Poor Prognosis After Resection of Non-small Cell Lung Cancer?
    Takamori S; Okamoto T; Mori M
    Ann Surg Oncol; 2020 Dec; 27(Suppl 3):834-835. PubMed ID: 32642994
    [No Abstract]   [Full Text] [Related]  

  • 10. ASO Author Reflections: Transdiaphragmatic Approach for Simultaneous Resection of Colorectal Liver and Lung Metastases.
    De Bellis M; Mehran RJ; Vauthey JN
    Ann Surg Oncol; 2020 Dec; 27(Suppl 3):859-860. PubMed ID: 32712888
    [No Abstract]   [Full Text] [Related]  

  • 11. ASO Author Reflections: Using Patient-Reported Outcomes to Compare Thoracoscopic Segmentectomy and Lobectomy.
    Dai W; Mu Y; Chang S; Wu Z; Che G
    Ann Surg Oncol; 2022 Jan; 29(1):557-558. PubMed ID: 34671885
    [No Abstract]   [Full Text] [Related]  

  • 12. ASO Author Reflections: Individualized Mediastinal Lymph Node Dissection for Lung Cancer: Do Not Neglect Station 3A Lymph Node.
    Liu C; Wei S; Liu L
    Ann Surg Oncol; 2020 Dec; 27(Suppl 3):846-847. PubMed ID: 32691340
    [No Abstract]   [Full Text] [Related]  

  • 13. ASO Author Reflections: The Possibility of a New Prognostic Biomarker of Pericardial Fat Volumes in Resected Non-small Cell Lung Cancer.
    Shinohara S; Kobayashi K; Nakagawa M
    Ann Surg Oncol; 2020 Feb; 27(2):490-491. PubMed ID: 31659635
    [No Abstract]   [Full Text] [Related]  

  • 14. ASO Author Reflections: Prognostic Impact of the Primary Tumor Resection for Lung Cancer Patients Diagnosed with Pleural Dissemination in the Perioperative Period-Importance of Biomarker-Based Treatment Decision Making.
    Shien K; Fujiwara T; Toyooka S
    Ann Surg Oncol; 2023 Oct; 30(11):6703-6704. PubMed ID: 37355523
    [No Abstract]   [Full Text] [Related]  

  • 15. ASO Author Reflections: Pure and Combined Surgically Resected Large Cell Neuroendocrine Carcinoma of Lung: Could They be Evaluated as a Single Entity?
    Wang Y; Han B
    Ann Surg Oncol; 2022 Sep; 29(9):5679-5680. PubMed ID: 35511389
    [No Abstract]   [Full Text] [Related]  

  • 16. ASO Author Reflections: Pulmonary Metastasectomy in Patients with Lung Metastases from Nasopharyngeal Carcinoma.
    Zhao ZR; Long H
    Ann Surg Oncol; 2021 Aug; 28(8):4551-4552. PubMed ID: 33586071
    [No Abstract]   [Full Text] [Related]  

  • 17. ASO Author Reflections: Impact of Ground-Glass Opacity Components in Long-Term Survivors with Resected Lung Adenocarcinoma.
    Shigefuku S; Shimada Y
    Ann Surg Oncol; 2021 Jan; 28(1):157-158. PubMed ID: 33067744
    [No Abstract]   [Full Text] [Related]  

  • 18. ASO Author Reflections: A Simple Method to Predict Risk Factors of Complications After Pneumonectomy.
    Li Z; He W; Wang C
    Ann Surg Oncol; 2022 Jan; 29(1):570-571. PubMed ID: 34379252
    [No Abstract]   [Full Text] [Related]  

  • 19. ASO Author Reflections: Usefulness of Visual Evaluation of PET in Predicting Prognosis after Lung Resection for Early-Stage Lung Adenocarcinoma and Selecting Candidates for Sublobar Resection.
    Kagimoto A; Tsutani Y; Okada M
    Ann Surg Oncol; 2021 Apr; 28(4):2076-2077. PubMed ID: 32965613
    [No Abstract]   [Full Text] [Related]  

  • 20. ASO Author Reflections: CTNNB1 and Fusion Genes as Predictors for Recurrence in Resected Early-Stage Lung Adenocarcinoma.
    Kim IA; Kim WS; Lee KY
    Ann Surg Oncol; 2021 Jul; 28(7):3994-3995. PubMed ID: 33151506
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.